This round is no longer accepting investments, but others just like it are live now.

CLOSED

GET A PIECE OF AVACEN MEDICAL

Pain-Free Is Freedom!

AVACEN (Advanced VAscular Circulation ENhancement) Medical provides FDA Cleared, noninvasive, drug-free over-the-counter pain relief and wellness devices, as well as diagnostics for cardiovascular disease and stress. The company has raised $4 million, sold over 9,000 devices, and has safely completed over 22 million treatments to date.

Show more

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Company Image

REASONS TO INVEST

Reasons Icon
Pain is the #1 reason for medical visits, with up to 116 million people in the US and 30% of the global population suffering from chronic pain. AVACEN is helping to solve this problem without the use of drugs or other invasive treatments. Our FDA 510(k) Cleared family of Class II medical devices use a patented thermotherapy platform technology to noninvasively increase blood flow in approximately 10 billion of the body’s smallest blood vessels.
Reasons Icon
AVACEN recently launched its 3rd-generation family of fully developed, high-demand, unique consumer and practitioner products into the expanding wellness market that grew to $4.4 trillion globally in 2022.
Reasons Icon
The AVACEN team is backed by successful leaders who have helped the company secure 17 patents and complete 10 pilot studies all supporting billion-dollar market opportunities such as chronic pain, type 2 diabetes, wound healing, fibromyalgia, and opioid addiction.

TEAM

Anthony Shimkin

Anthony Shimkin • CEO, President, Director

25 years of Fortune 500 and startup executive experience in sales, marketing, strategy and business development in medical devices, diagnostics, and HCIT. Throughout his extensive career, Mr. Shimkin held key marketing and innovation leadership roles at several notable companies, including Qualcomm, where he served as senior director of marketing and later, senior director of business development. Before that, he held senior executive positions at Lantronix, Quidel, Cardinal Health, Alaris Medical Systems and Neoforma. He also led the health care equity research team at Wedbush Securities and consulted for leading life sciences companies including Abbott, Boston Scientific, Genentech, Roche and Sanofi. Anthony received his M.B.A. from Boston University, a M.A. from Boston University School of Medicine, a M.S. from the University of San Diego, and a B.A. from Boston University.

Read More

Thomas Muehlbauer

Thomas Muehlbauer • Chairman, President, Co-Founder, Product Inventor, and R&D Head

Fortune 500 senior executive experience with over 40 years of CEO and startup skills including acquisitions, capital formation and public market transitions. Prior to founding AVACEN in 2009, Mr. Muehlbauer started an Internet company which was sold to a publicly traded company, bringing a return to founding investors of over 180% in 2 years. As a hands-on investor, he engineered the startup growth and sale of World View, International, providing multimillion dollar returns to shareholders in less than a three-year period.

Read More

Danielle Forsgren

Danielle Forsgren • CMO, Co-Founder, and Board Member

Danielle has over 40 years of experience in sales and marketing. She has extensive theatre, radio, public speaking and TV experience including multiple appearances on QVC. As the Company’s top salesperson and Chief Marketing Officer, she is currently developing several strategic initiatives to globally expand sales. Her efforts of the last 3 years have placed the Company on the INC. 5000 list of fastest growing companies in the US. She studied at International University and the University of San Diego.

Read More

ABOUT

HEADQUARTERS
6451 El Camino Real, Suite C
Carlsbad, CA 92009
WEBSITE
View Site
AVACEN (Advanced VAscular Circulation ENhancement) Medical provides FDA Cleared, noninvasive, drug-free over-the-counter pain relief and wellness devices, as well as diagnostics for cardiovascular disease and stress. The company has raised $4 million, sold over 9,000 devices, and has safely completed over 22 million treatments to date.

ALL UPDATES

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign reward.

JOIN THE DISCUSSION

0/2500

YH
Yosef Hertz

2 years ago

What is your YTD revenue? Can you give more info on how you plan to exit in the next 12 months? And the type of opportunity you're working on and why your closing the campaign early? Thanks

Show more

0

0

DA
David Amin

2 years ago

$75M valuation on a paltry profit. Comeptition is ready so what is the exit strategy ?

1

0

RK
Richard Koch

2 years ago

I'm a chronic pain patient. When I lived in Carlsbad, for 15 years, Pacific Pain in Oceanside were my pain docs who implanted a pain pump. Fast forward about a decade and I'm recovering from 7 fusions in C to T spine. Forgive me if I'm a tad skeptical. 1. Can I assume you're dealing with pain doctors who are actually anesthiologists with certificates in pain management? You know, honest to God pain doctors? Not just somebody with a shingle out that has the word "pain" in the business name? 2. I've been tossing narcotics down my neck since 1991. I've been through some bizarre compounds in my pump, including Prialt (bad juju). This would therapy put all that nonsense to a stop? (Maybe I should ask "could it?" I've gotta manage expectations.) 3. After over thirty years, you're telling me this REALLY works? For someone like me? Or simply for the routine aches and pains that normal people deal with? 4. All that said, I'd love to investing a magic bullet. I've got a pump refill today, so what should I ask my pain doc? I'd like to pose some hypothetical questions to him........ Just askin'

Show more

3

0

BS
BENJAMIN SAVILL

2 years ago

I am investor #133. I just tried Avacen for the first time last week and really liked what I saw and what I heard from distributor Neil Myers here in Orange County, California. I am hopeful that this could be the solution to my 15 years of chronic pain and inflammation, and I look forward to purchasing a device and becoming a distributor. You have written in this pitch that you will use the funds raised via StartEngine (so far around $200,000 less whatever StartEngine takes) to 1. complete your studies on Fibromyalgia, Type II Diabetes and Wound Healing, 2. pursue additional clinical indications for AVACEN devices, 3. continue developing devices that will help treat pain, while you work toward additional clinical indications, 4. continue to acquire devices (like the recent 100% acquisition of CATHHSTA) to reduce pain, improve cardiac health, and enhance wellness. That's a hell of a lot of things to do with very little money. What will be your order of priority, and how much of the raise will you allocate to each priority?

Show more

1

0

CD
Cayla Donohoue

2 years ago

Highly recommend using an AVACEN device, especially if you're pregnant! I suffered from sciatic nerve pain during my second trimester and received instant relief by using my device 4x a day. As a result, that sciatic nerve was gone completely for the rest of my pregancy. Our baby even came out with A LOT of blonde hair on her head too, and we credit that to the circulation she was getting while I was using the device religiously during my pregnancy. When we got the opportunity to invest in AVACEN, it was a no-brainer. We are happy to be investors with this incredible, life changing, device.

Show more

0

0

CD
Chad Donohoue

2 years ago

Absolutely love our Avacen device! Great product with amazing results for our whole family! My mom began using it while on chemo and it completely took away the main side effect of neuropathy and really helps her back pain, my wife uses it for stress relief, and I use it to improve my circulation and overall health! So thankful for this opportunity to invest!

Show more

1

0

GH
Grigore Hreniuc

2 years ago

According to your website, the company has been in business for 15 years. Where do the devices are manufactured? The cost of $5K-$10K for a device is high and comes with only 12 months warranty. The average consumer can't afford the price. Does Medicare cover any of your devices? I notice your device is FDA-cleared. Do you have plans to have this device FDA-approved?

Show more

1

0

JS
John Sklarosky

2 years ago

Hello. Could you explain the high valuation? Just seems a bit high.

1

0

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

FAQ Timeline

WHY STARTENGINE?

Rewards Icon
REWARDS

We want you to succeed and get the most out of your money by offering rewards and memberships!

Lock Icon
SECURE

Your info is your info. We take pride in keeping it that way!

Ellipse Icon
DIVERSE INVESTMENTS

Invest in over 200 start-ups and collectibles!

FAQS

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.

StartEngine makes it easy to invest using your retirement funds. You can open a self-directed IRA account through Equity Trust, a trusted provider fully integrated with our platform. This integration allows for a fast, secure, and seamless investing experience, and includes a special offer on annual feesexclusively for StartEngine investors.

Already have a self-directed IRA with another provider? You can still invest on StartEngine, but please note that the process will be manual and may take longer to complete.

To get started, simply visit our IRA page for more information and step-by-step instructions.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancellation period. Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.

www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.

Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary LLC (“SE Primary”), a broker-dealer registered with the SEC and FINRA / SIPC. You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system (ATS) regulated by the SEC and operated by SE Primary. SE Primary is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.

StartEngine facilitates three types of primary offerings:

1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.

Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice concerning any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy, or completeness of any information. Neither StartEngine nor any of its officers, directors, agents, and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site.

Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment. See additional general disclosures here.

By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.

Canadian Investors

Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.

California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.

StartEngine Marketplace (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC.

StartEngine Secondary (“SE Secondary”) is our investor trading platform. SE Secondary is an SEC-registered Alternative Trading System (“ATS”) operated by SE Primary that matches orders for buyers and sellers of securities. It allows investors to trade shares purchased through Regulation A+, Regulation Crowdfunding, or Regulation D for companies who have engaged StartEngine Secure LLC as their transfer agent. The term “Rapid,” when used in relation to transactions on SE Marketplace, specifically refers to transactions that are facilitated on SE Secondary, This is because, unlike with trades on the StartEngine Bulletin Board (“SE BB”), trades on SE Secondary are executed the moment that they are matched.

StartEngine Bulletin Board (“SE BB”) is a bulletin board platform on which users can indicate to each other their interest to buy or sell shares of private companies that previously executed Reg CF or Reg A offerings not necessarily through SE Primary. As a bulletin board platform, SE BB provides a venue for investors to access information about such private company offerings and connect with potential sellers. All investment opportunities on SE BB are based on indicated interest from sellers and will need to be confirmed. Even if parties express mutual interest to enter into a trade on SE BB, a trade will not immediately result because execution is subject to additional contingencies, including among others, effecting of the transfer of the shares from the potential seller to the potential buyer by the issuer and/or transfer agent. SE BB is distinct and separate from SE Secondary. SE Secondary facilitates the trading of securities by matching orders between buyers and sellers and facilitating executions of trades on the platform. By contrast, under SE BB, SE Primary assists with the facilitation of a potential resulting trade off platform including, by among other things, approaching the issuer and other necessary parties in relation to the potential transaction. The term “Extended”, when used in relation to transactions on SE Marketplace denotes that these transactions are conducted via SE BB, and that these transactions may involve longer processing times compared to SE Secondary for the above-stated reasons.

Even if a security is qualified to be displayed on SE Marketplace, there is no guarantee an active trading market for the securities will ever develop, or if developed, be maintained. You should assume that you may not be able to liquidate your investment for some time or be able to pledge these shares as collateral.

The availability of company information does not indicate that the company has endorsed, supports, or otherwise participates with StartEngine. It also does not constitute an endorsement, solicitation or recommendation by StartEngine. StartEngine does not (1) make any recommendations or otherwise advise on the merits or advisability of a particular investment or transaction, (2) assist in the determination of the fair value of any security or investment, or (3) provide legal, tax, or transactional advisory services.